239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018

•Dermatomyositis-specific autoantibodies define unique clinical phenotypes. •Standardized autoantibody detection methods are needed. •Patients with antisynthetase autoantibodies do not have dermatomyositis. •A new dermatomyositis classification scheme was proposed.